1Tagliaferri W, Berselli ME, Calo G, et al. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res, 2001,9:196-201.
2Folsom AR, Burke GL, Ballew C, et al. Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites. The role of insulin. Am J Epidemiol, 1989,130:911-924.
3Ronnemaa T, Marniemi J, Savolainen MJ, et al. Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity. J Clin Endocrinol Metab, 1998, 83:2792-2799.
4Meier C, Staub JJ, Roth CB, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double-blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab, 2001,86:4860-4866.
5Miyakawa M, Tsushima T, Murakami H, et al. Serum leptin levels and bioelectrical impedance assessment of body composition in patients with Graves' disease and hypothyroidism. Endocr J, 1999,46:665-673.
6al-Adsani H, Hoffer LJ, Silva JE. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab, 1997,82:1118-1125.
7Bauer DC, Ettinger B, Browner WS. Thyroid functions and serum lipids in older women: a population-based study. Am J Med, 1998,104:546-551.
8Diekman T, Demacker PN, Kastelein JJ, et al. Increased oxidizability of low-density lipoproteins in hypothyroidism. J Clin Endocrinol Metab, 1998,83:1752-1755.
9Wolf M, Weigert A, Kreymann G. Body composition and energy expenditure in thyroidectomized patients during short-term hypothy-roidism and thyrotropin-suppressive thyroxine therapy. Eur J Endo-crinol, 1996,134:168-173.
10Staels B, van Tol A, Chan L, et al. Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase and low density lipoprotein receptor in rats. Endocrinology, 1990,127:1144-1152.
